Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data

Clinical Gastroenterology and Hepatology(2023)10.1016/j.cgh.2023.01.005Source: DataRank Database

Net Remission Rates with Biologic and Small Molecule Treatment in Ulcerative Colitis: A Reappraisal of the Clinical Trial Data is a research paper published in Clinical Gastroenterology and Hepatology (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

20 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.24)OA: closedTopics (20)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Hannah Posner,Elizabeth A. Spencer ORCID,Jean‐Frédéric Colombel ORCID,Carlos Stalgis,Ryan C. Ungaro ORCID

Live enrichment

PubMed:36640802 OpenAlex:https://openalex.org/W4315607844

National Institutes of Health

Grant: K23DK127241-01A1

National Institutes of Health

Grant: K23KD111995-01A1

NIDDK NIH HHS

Grant: K23 DK127241

NIDDK NIH HHS

Grant: K23 DK111995

FWCI

5.24

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S1542356523000356?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1542356523000356?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cgh.2023.01.005

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36640802

Fields of Study

Inflammatory Bowel DiseaseMicroscopic ColitisHealth Systems, Economic Evaluations, Quality of LifeHumansColitis, UlcerativeMesalamineAnti-Inflammatory Agents, Non-SteroidalBiological ProductsRemission Induction

MeSH Terms

Anti-Inflammatory Agents, Non-SteroidalBiological ProductsColitis, UlcerativeHumansRemission InductionMesalamine

Keywords

MedicineUlcerative colitisClinical trialInternal medicineDisease

Sustainable Development Goals

SDG 0: Good health and well-being